Piloni Davide, Bertuccio Francesco R, Primiceri Cristiano, Rinaldi Pietro, Chino Vittorio, Abbott David Michael, Sottotetti Federico, Bortolotto Chandra, Agustoni Francesco, Saddi Jessica, Stella Giulia M
Cardiothoracic and Vasculat Department, Unit of Respiratory Diseases, IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
Medical School, University of Pavia, 27100 Pavia, Italy.
J Clin Med. 2023 Feb 16;12(4):1561. doi: 10.3390/jcm12041561.
Growing evidence suggests that sublobar resections offer more favorable outcomes than lobectomy in early-stage lung cancer surgery. However, a percentage of cases that cannot be ignored develops disease recurrence irrespective of the surgery performed with curative intent. The goal of this work is thus to compare different surgical approaches, namely, lobectomy and segmentectomy (typical and atypical) to derive prognostic and predictive markers.
Here we analyzed a cohort of 153 NSCLC patients in clinical stage TNM I who underwent pulmonary resection surgery with a mediastinal hilar lymphadenectomy from January 2017 to December 2021, with an average follow-up of 25.5 months. Partition analysis was also applied to the dataset to detect outcome predictors.
The results of this work showed similar OS between lobectomy and typical and atypical segmentectomy for patients with stage I NSCLC. In contrast, lobectomy was associated with a significant improvement in DFS compared with typical segmentectomy in stage IA, while in stage IB and overall, the two treatments were similar. Atypical segmentectomy showed the worst performance, especially in 3-year DFS. Quite unexpectedly, outcome predictor ranking analysis suggests a prominent role of smoking habits and respiratory function, irrespective of the tumor histotype and the patient's gender.
Although the limited follow-up interval cannot allow conclusive remarks about prognosis, the results of this study suggest that both lung volumes and the degree of emphysema-related parenchymal damage are the strongest predictors of poor survival in lung cancer patients. Overall, these data point out that greater attention should be addressed to the therapeutic intervention for co-existing respiratory diseases to obtain optimal control of early lung cancer.
越来越多的证据表明,在早期肺癌手术中,肺叶下切除术比肺叶切除术能带来更有利的结果。然而,无论手术是否具有治愈意图,仍有一定比例不可忽视的病例会出现疾病复发。因此,本研究的目的是比较不同的手术方法,即肺叶切除术和肺段切除术(典型和非典型),以得出预后和预测标志物。
我们分析了2017年1月至2021年12月期间接受肺切除手术并进行纵隔肺门淋巴结清扫术的153例临床TNM I期非小细胞肺癌患者队列,平均随访25.5个月。还对数据集进行了分区分析以检测结果预测因素。
本研究结果显示,I期非小细胞肺癌患者的肺叶切除术与典型和非典型肺段切除术的总生存期相似。相比之下,在IA期,肺叶切除术与无病生存期的显著改善相关,而在IB期及总体上,两种治疗方法相似。非典型肺段切除术表现最差,尤其是在3年无病生存期方面。相当出乎意料的是,结果预测因素排名分析表明,无论肿瘤组织学类型和患者性别如何,吸烟习惯和呼吸功能都起着重要作用。
尽管有限的随访间隔无法对预后做出确定性结论,但本研究结果表明,肺容量和与肺气肿相关的实质损伤程度都是肺癌患者生存不良的最强预测因素。总体而言,这些数据指出,应更加关注对并存呼吸系统疾病的治疗干预,以实现对早期肺癌的最佳控制。